✦ LIBER ✦

National trials involving lymphatic mapping for melanoma: the multicenter selective lymphadenectomy trial, the sunbelt melanoma trial, and the florida melanoma trial

✍ Scribed by Douglas Reintgen; Solange Pendas; James Jakub; Gray Swor; Rosemary Giuliano; Jan Bauer; Robert Cassall; Lisa Duhaime; Marwin Alsarrai; Steve Shivers

Book ID: 114473516
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 226 KB
Volume: 31
Category: Article
ISSN: 0093-7754
DOI: 10.1053/j.seminoncol.2004.03.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The staging of malignant melanoma and th

The staging of malignant melanoma and the florida melanoma trial

✍ Douglas S. Reintgen; James W. Jakub; Solange Pendas; Gray Swor; Rosemary Giulian 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 866 KB

THE PLACE OF SENTINEL NODE BIOPSY IN MEL

THE PLACE OF SENTINEL NODE BIOPSY IN MELANOMA AFTER THE MULTICENTER SELECTIVE LYMPHADENECTOMY TRIAL

✍ J. Meirion Thomas 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

BENEFITS OF SENTINEL NODE BIOPSY FOR MEL

BENEFITS OF SENTINEL NODE BIOPSY FOR MELANOMA: A REVIEW BASED ON INTERIM RESULTS OF THE FIRST MULTICENTER SELECTIVE LYMPHADENECTOMY TRIAL

✍ J. F. Thompson; H. M. Shaw 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

The Impact on Morbidity and Length of St

The Impact on Morbidity and Length of Stay of Early Versus Delayed Complete Lymphadenectomy in Melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I)

✍ Mark B. Faries; John F. Thompson; Alistair Cochran; Robert Elashoff; Edwin C. Gl 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 380 KB

Surgical adjuvant active specific immuno

Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial

✍ Marc K Wallack; Muthukumaran Sivanandham; Charles M Balch; Marshall M Urist; Kir 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 240 KB

Strategy of the EORTC-MCG trial programm

Strategy of the EORTC-MCG trial programme for adjuvant treatment of moderate-risk and high-risk melanoma

✍ A.M.M. Eggermont 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 72 KB